FindMyRecallSubscribe
Class I: serious health riskTerminated

Impax Laboratories Lamotrigine Orally Disintegrating Tablets Recall

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containi…

Impax Laboratories, Inc. · Hayward, CA

Risk level
Class I
Reported by FDA
Dec 28, 2016
Recall ID
D-0215-2017
Check your lot numberHow we source this data

Summary

Impax Laboratories recalled Lamotrigine Orally Disintegrating Tablets starting Aug 19, 2016. The FDA classified it as Class I (serious health risk) and published enforcement report D-0215-2017 on Dec 28, 2016. Reason: Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs. Status: Terminated.

Why it was recalled

Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs

Product description

Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA

Lot numbers, UPCs & expiration codes

Lot Number 502240, expiry date 11/2017

Where it was sold

Distributed Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0215-2017
Classification
Class I
Status
Terminated
Recall initiated
Aug 19, 2016
FDA report date
Dec 28, 2016
Quantity
3,074 boxes (30 count boxes)
Recall type
Voluntary: Firm initiated
Recalling firm
Impax Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0215-2017, exactly as published.

Show all FDA fields
City
Hayward
State
CA
Status
Terminated
Country
United States
Event ID
74953
Address
31153 San Antonio Street
Code information
Lot Number 502240, expiry date 11/2017
Postal code
94544
Report date
Dec 28, 2016
Product type
Drugs
Recall number
D-0215-2017
Classification
Class I
Recalling firm
Impax Laboratories, Inc.
Product quantity
3,074 boxes (30 count boxes)
Termination date
Jun 1, 2017
Reason for recall
Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA
Distribution pattern
Distributed Nationwide
Recall initiation date
Aug 19, 2016
Initial firm notification
Letter
Center classification date
Dec 22, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0215-2017, published Dec 28, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls